How do the Anti-HIV drugs woks? By Tawitch Suriyo Master degree of Toxicology Mahidol University.

Slides:



Advertisements
Similar presentations
Fundamentals of Biochemistry
Advertisements

HIV and its lifecycle Sources: Wikipedia, HIV is a retrovirus (enveloped viruses possessing an RNA genome,
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Twelfth Edition© 2015 Pearson Education, Inc Viruses HIV causes AIDS, which.
Treating HIV with Azidothymidine (AZT) A Design by Jeanine Nasser.
The gp41 fragment (purple) consists of a cytoplasmic tail and a hydrophobic membrane-spanning domain and is joined with the larger gp120 component (blue.
Mutations and Genetic Diseases DNAmRNAAAProperties of AAAffect CTCGAGGluHydrophilic/AcidicNormal CTTGAAGluHydrophilic/AcidicNone (Silent) CTAGAUAspHydrophilic/AcidicNone.
1 Antiviral Drugs Limited selective toxicity –Viruses mostly use host cell machinery, so very few unique targets –Most drugs block steps that take place.
Basics of Molecular Biology
HIV Replication Rachel Carriger Biochemistry Fall 2004.
HIV and AIDS Human Immunodeficiency Virus (HIV) is the virus that causes Acquired Immunodeficiency Syndrome (AIDS).
Genetic Mutations Recombinant DNA Viruses Chapter 22 Nucleic Acids and Protein Synthesis.
Transcription strategies of viruses
Vaccines and Antivirals. Clinical Use of Interferon Therefore they have been used in the treatment of cancers of various types. Therefore they have been.
CHAPTER 20 Microbial Growth Control. Physical Antimicrobial Control Heat Sterilization Sterilization is the killing of all organisms, including viruses.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Lecture 29: Viruses 0.5 m.
HIV-1 Protease HIV-1 Protease is one of the targets in the therapeutic treatment of AIDS. It cleaves the nascent polyproteins of HIV-1 and plays an essential.
Transcription & Translation
Lecture 27 Pharmacology Flint et al., Chapter 19, pp. 725 – 757.
Anti-HIV Drugs Cathy Molina November 11, Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to.
Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies.
Antivirals for HIV Yasir Waheed, PhD. Some HIV Facts HIV – the Human Immunodeficiency Virus is the retrovirus that causes AIDS HIV belongs to the retrovirus.
1 Mukund Modak, Ph. D. Dental Biochemistry 2013 Lecture 39.
Chemistry: An Introduction to General, Organic, and Biological Chemistry, Eleventh Edition Copyright © 2012 by Pearson Education, Inc. Chapter 17 Nucleic.
Genetic Mutations A mutation alters the nucleotide sequence in DNA, which can cause a change in the amino acid structure of the corresponding protein,
Clinical group Marketing group Production group New Approach group Ethics group Final Presentation.
Chapter 10 – DNA, RNA, and Protein Synthesis
Antiviral Chemotherapy Discovery of antiviral drugs Targets of antiviral drugs.
ATP Immediate source of energy that drives cellular work Adenosine triphosphate Nucleotide with unstable phosphate bonds Phosphate bonds easily hydrolyzed.
RITONAVIR INTERACTIONS AND SIDE EFFECTS Present by PEERAKARN BANJERDKIJ.
Gene Expression and Control
Anti-HIV Drugs Melissa Morgan Medicinal Chemistry November 23, 2004.
The Genetic Code.
PROTEIN SYNTHESIS THE FORMATION OF PROTEINS USING THE INFORMATION CODED IN DNA WITHIN THE NUCLEUS AND CARRIED OUT BY RNA IN THE CYTOPLASM.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display The Steps in HIV Replication Slide number 1 (1) Viral.
Nucleic Acids The nucleic acids DNA and RNA consist of monomers called nucleotides that consist of a Pentose sugar. Nitrogen-containing base. Phosphate.
HIV molecular biology BTY328: Virology
Retroviruses (Chap. 15, p.308) and Gene Regulation (Chap. 14) HIV (human immunodeficiency virus)
HIV Life Cycle Step 1: Fusion Step 2: Transcription reverse transcriptase Step 3: Integration Step 4: Cleavage Step 5: Packaging and Budding HIV.
HIV Human Immunodeficiency Virus
Two different therapeutic approaches for treating: A.A DNA virus (e.g. Herpes) B.An RNA virus (e.g. Influenza)
Protein Synthesis How genes work.
© 2005 Jones and Bartlett Publishers Chapter 18 How Genes Work and How Genes are Controlled.
Antiviral drugs.
HCV Protease Yasir Waheed. Discovery of Hepatitis C.
Basics of Human Immunodeficiency Virus (HIV) Brian Rybarczyk, PhD University of North Carolina- Chapel Hill.
Acyclovir Lee, sang-hwi.
Immune reconstitution Anjie Zhen, PhD
Investigation of the enzymatic processes depending on the type of reaction.
항바이러스제 Ritonavir 양혜란. Ritonavir 화학명 1,3-Tiazol-5-ylmethyl[3-hydroxy-5-[3-methyl-2-[methyl-[(2-propan-2- yl-1,3-thiazole-4-yl)methyl]carbamoyl]-aminobutanoyl]amino-1,6-
The HIV virus. Objectives At the end of this session the participants will be able to: 1. Understand basic HIV structure 2. Describe the significance.
General, Organic, and Biological Chemistry Copyright © 2010 Pearson Education, Inc Viruses Chapter 21 Nucleic Acids and Protein Synthesis.
HIV-1 PROTEASE Presented by: Aruni karunanyake
Viro100: Virology 3 Credit hours NUST Centre of Virology & Immunology
Retrovirus HIV (humans) Animal viruses resulting in cancer / AIDS 15-39%
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Serine Proteases Components of the enzymatic pocket:
Chapter 10 – DNA, RNA, and Protein Synthesis
Antiviral chemotherapy
Of drug cocktails and inhibited enzymatic rates
Protease.
HIV Integrase Therapeutics
Structure and Function Laura Martin
Replication life cycle of HIV and sites of antiretroviral drug action.
Proteins: Building Blocks of Life
Chapter 18 How Genes Work and How Genes are Controlled
Terminology HIV AIDS Acquired Human Immune Immunodeficiency Deficiency
Chapter 17 Nucleic Acids and Protein Synthesis
Antiviral chemotherapy
Presentation transcript:

How do the Anti-HIV drugs woks? By Tawitch Suriyo Master degree of Toxicology Mahidol University

How do anti-HIV drugs work? Content The step of HIV life cycle that might be stopped. The types of anti-HIV drugs that we have now Reverse Transcriptase Inhibitors Integrase Inhibitors Protease Inhibitors

The step of HIV life cycle that might be stopped Attachment 2.Reverse transcriptase 3.Integrase & transcription 4.Translation 5.viral protease 6.assembly & budding

1.Attachment The step of HIV life cycle that might be stopped.

2.Reverse Transcriptase

The step of HIV life cycle that might be stopped. 3.Integration,Transcription Viral DNA joins host DNAMaking multiple viral RNAs

The step of HIV life cycle that might be stopped. 4.Translation

5.Viral Protease

The step of HIV life cycle that might be stopped. 6.Assembly & Budding

The step of HIV life cycle that might be stopped.

Types of anti-HIV drugs that we have now. Reverse Transcriptase Inhibitors Integrase Inhibitors (clinical trial) Protease Inhibitors

Reverse Transcriptase Inhibitor Nucleoside analog E.g. AZT,ddI,ddC,d4T Non-nucleoside analog E.g. Nevirapine,Delavirdine

Reverse Transcriptase Inhibitor Nucleoside analog These agents are both inhibitors and substrates of RT, broad in family of 2’-3’-dideoxynucleoside Need metabolism before functional Competitive inhibition with dNTP Incorperation into the viral DNA lead to DNA termination

Reverse Transcriptase Inhibitor Nucleoside analog need metabolize

Reverse Transcriptase Inhibitor Nucleoside analog + Incorporation lead to DNA chain termination

Reverse Transcriptase Inhibitor Nucleoside analog : Zidovudine or AZT + Thymidine analog + 3’-azido-2’,3’-dideoxythymidine + MW fomular C 10 H 13 N 5 O 4

Reverse Transcriptase Inhibitor Nucleoside analog : Zidovudine or AZT The mechanism of action of AZT +Metabolize of AZT

Reverse Transcriptase Inhibitor Nucleoside analog : Zidovudine or AZT AZT-DP bind with NDP-K

Reverse Transcriptase Inhibitor Nucleoside analog : Zidovudine or AZT AZT-TP +competitive inhibit RT with respect to TTP +incorporate into growing chain of DNA +AZT reduce the amount of dNTP (decreasing competition for AZT-TP)

Reverse Transcriptase Inhibitor Nucleoside analog : Zidovudine or AZT AZT-TP +Low concentration onhibit DNA polymerase +distrub growing of cellular DNA chain

Reverse Transcriptase Inhibitor Non-nucleoside analog Structurally heterogenous Active for HIV-1 only Not need metabolism before functional Interact with a nonsubstrate binding site Noncompetitive inhibition

Reverse Transcriptase Inhibitor Non-nucleoside analog : Nevirapine Viramune (trade name) MW fumular C 15 H 14 N 4 O

Reverse Transcriptase Inhibitor Non-nucleoside analog : Nevirapine The machanism action of nevirapine +bind directly to RT +block RT activity (RNA dependent and DNA-dependent DNA polymerase) by distrub the RT’s catalytic site (110 Asp,185Asp and 186 Asp triad)

Reverse Transcriptase Inhibitor Non-nucleoside analog : Nevirapine +not compete with template or nucleoside tritposphate +not inhibit HIV-2 RT and cellular DNA polymerase

Integrase Inhibitor HIV integrase is a viable therapeutic strategy that will abort completion of the viral life cycle The commercial drug of this type not have yet now. Some drug just under clinical trial. E.g. Zintevir currently in Phase I/II clinical trial.

Integrase Inhibitor Overview of integration the formation of the ISC the 3’-processing in reaction the DNA strand transfer

Integrase Inhibitor HIV-Integrase a protein of 32 kDa function for intergrate viral cDNA into human DNA recognizes specific sequence in LTR in viral cDNA composed of 3 functional domain active form is oligomer ( by oligomerization)

Integrase Inhibitor Different approches to interfering the integration triple helix-mediated inhibition inhibition IN by peptides derived from combinatirial peptides chemistry. Screening of chemical libraries and natural compounds. Inhibition by G-quartet forming oligonucleotides

Integrase Inhibitor Triple helix-mediated inhibition oligonucleotide readly form stable complex with viral DNA triplex formation prevent catalytic function of IN

Integrase Inhibitor Inhibition IN by peptides derived from combinatirial peptides chemistry.find critical potion of IN by change amino acid that make IN loss its functional

Integrase Inhibitor Screening of chemical libraries and natural compounds..find the chemical ( oligonucleotide-base) that inhibit function of IN. Device into 3 categories +DNA binding agent +Polyhydroxylated aromatic compound +Nucleotides

Integrase Inhibitor Inhibition by G-quartet forming oligonucleotides oligonucleotides composed of base deoxyguanosine and thymidine in presence of K+, Its form G-quartet G-quartet can inhibit HIV replication by +inhibit viral entry into cell +and/or inhibition HIV IN

Integrase Inhibitor stable oligonucleotides of 17 nucleotides composed only deoxyguanosine and thymidine,with single phosphorothioate internucleoside linkages at 5’ and 3’ end. Fumular 5’-GTGGTGGGTGGGTGGGT-3’ Zintevir or AR-177

Integrase Inhibitor Form a highly stable intramolecular four- stranded DNA contain two stacked G-quartet Zintevir (G-quartet) inhibit HIV-1 IN activity Zintevir or AR-177

Integrase Inhibitor The machanism of action of Zintevir its inhibit integration in only step of the formation of ISC by +G-quartet interact with IN +it not bind to DNA binding domain but its interact with zinc finger domain of IN +IN can’t form active form (oligomer) +IN can’t bind with viral DNA Zintevir or AR-177

Protease Inhibitor Protease enzyme As aspartyl protease. Consist of 2 symmetric subunit each subunit consist 99 amino acid single active site catalytic site conserve catalytic triads ( Asp-Thr-Gly)

Protease Inhibitor Protease enzyme Cleavage polypeptide to functional enzyme and structural protein muation in catalytic site (Asp->Ala) cause immature virus (can’t infect new cell) HIV protease no cross-reactivity with human cellular protease

Protease Inhibitor Activities of HIV protease enzyme

Protease Inhibitor Protease inhibitor Slow down the action of HIV protease e.g. Ritonavir, Indinavir,Saquinavir

Protease Inhibitor Protease inhibitor Base on transitionstate mimetics of peptide substrate interact with catalytic residues and displace a structural water molecule the interaction protease and protease inhibitor complex cause enzyme not functional properly.

Protease Inhibitor Native HIV Protease HIV Protease with inhibitor

Protease Inhibitor Protease inhibitor : Ritonavir Norvir (trade name) or ABT-583 a white-to light-tan powder formular C 37 H 48 N 6 O 5 S 2 MW

Protease Inhibitor Protease inhibitor : Ritonavir A peptidomimetic inhibitor for HIV- 1,2 protease Its directly interact with HIV protease that cause this enzyme not function the interaction is hydrophobic interaction

Protease Inhibitor Protease inhibitor : Ritonavir hydrophobic interaction of P’3 isopropylthiazolyl group of ritonavir with active side chain of valine-82 (V82) of HIV protease mutation in V82 to Ala,Phe or Thr cause ritonavir resistance

Protease Inhibitor Protease inhibitor : Ritonavir Its metabolized by CYP 3A4 and also a potent inhibitor of CYP 3A4 inhibition of CYP by the unhindered nitrogen atom on the unsubatituted P2’ 5-thiazolyl group with bind directly to the heme in the CYP active site

Protease Inhibitor Protease inhibitor : Ritonavir P3’ isopropylthiazoly group P2’ 5- thiazoly group

Protease Inhibitor Protease - Ritonavir inhibitor complex.

Thank you for your attention